Carpipramine (Prazinil, Defekton) is an atypical antipsychotic used for the treatment of schizophrenia and anxiety in France and Japan.[1][2][3][4] In addition to its neuroleptic and anxiolytic effects, carpipramine also has hypnotic properties.[3] It is structurally related to both tricyclics like imipramine and butyrophenones like haloperidol.[3]

See also

References

  1. ^ Deniker P, Lôo H, Zarifian E, Verdeaux G, Garreau G (1977). "[A new psychotropic drug: carpipramine, intermediate compound between 2 therapeutic classes]". L'Encephale (in French). 3 (2): 133–148. PMID 19231.
  2. ^ Pislová J, Pisl I, Petránová T, Petrová M (August 1974). "Clinical experience with carpipramine (Defekton)". Activitas Nervosa Superior. 16 (3): 168–169. PMID 4608287.
  3. ^ a b c Párraga A, Holenz J, Buschmann H (2007). "Marketed Drugs in Development". In Vela JA, Buschmann H, Holenz J, Párraga A, Torrens A (eds.). Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. Weinheim: Wiley-VCH. ISBN 978-3-527-31058-6.[permanent dead link]
  4. ^ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 978-3-88763-075-1.